Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mark Erlander Insider Profile
4 Followers
Mark Erlander, CEO, Director at Cardiff Oncology, holds 24.48K shares in Cardiff Oncology (Ticker: CRDF). Most recently, Mark Erlander Bought $10,000 shares of Cardiff Oncology on Nov 29, 2022 for an estimated value of 14.30K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
+47.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
CEO, Director
Roles that Mark Erlander holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mark Erlander
Mark Erlander's Trading History
List of latest transactions for each holding click on a transaction to see Mark Erlander's performance on stock
You May Also Like
Mark Erlander insider profile FAQ
What is the percentage of profitable transactions made by Mark Erlander?
The percentage of profitable transactions made by Mark Erlander is 25%.
What is the average return per transaction made by Mark Erlander?
The average return per transaction made by Mark Erlander is 47.70%.
What stocks does Mark Erlander hold?
Mark Erlander holds: CRDF stocks.
What was Mark Erlander’s latest transaction?
Mark Erlander latest transaction was an Informative Buy of $14.30K.
What was Mark Erlander's most profitable transaction?
Mark Erlander’s most profitable transaction was an Informative Buy of CRDF stock on May 18, 2020. The return on the trade was 371.00%.
What is Mark Erlander's role in Cardiff Oncology?
Mark Erlander's role in Cardiff Oncology is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.